A vision statement on guideline development for respiratory disease: the example of COPD
暂无分享,去创建一个
H. Schünemann | K. Rabe | A. Anzueto | W. MacNee | J. Heffner | S. Buist | M. Woodhead | W. Macnee
[1] A. Oxman,et al. Chapter 12: Interpreting results and drawing conclusions , 2011 .
[2] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[3] Use of evidence in WHO recommendations , 2007, The Lancet.
[4] Keiji Fukuda,et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus , 2006, The Lancet Infectious Diseases.
[5] A. Oxman,et al. Improving the use of research evidence in guideline development: introduction , 2006, Health research policy and systems.
[6] Michael K Gould,et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.
[7] G. Guyatt,et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.
[8] P. Glasziou,et al. The paths from research to improved health outcomes , 2005, Evidence-based nursing.
[9] R. Horton. WHO: the casualties and compromises of renewal , 2002, The Lancet.
[10] Alessandro Liberati,et al. Practice guidelines developed by specialty societies: the need for a critical appraisal , 2000, The Lancet.
[11] Storm over WHO–ISH hypertension guidelines , 1999, The Lancet.